A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4439 (2006.01) A61K 9/36 (2006.01) A61K 9/50 (2006.01) A61P 1/04 (2006.01)
Patent
CA 2376226
An oral dosage form comprising a core material coated with a semipermeable membrane wherein the core material comprises an active ingredient selected from the group of omeprazole, an alkaline salt thereof, S-omeprazole and an alkaline salt thereof, in admixture with one or more alkaline additives, one or more swelling agents, and optionally pharmaceutically acceptable excipients, and the dosage form is not enteric coated.
Cette invention concerne une forme de dosage oral qui comprend qui comprend un matériau central enrobé d'une membrane semi-perméable. Le matériau central comprend un principe actif choisi dans le groupe comprenant un oméprazole, un sel alcalin de celui-ci, un <i>S)</i>-oméprazole et un sel alcalin de celui-ci. Le principe actif est mélangé à un ou plusieurs additifs alcalins, à un ou plusieurs agents de gonflement et, éventuellement, à des excipients acceptables sur le plan pharmaceutique. Cette forme de dosage n'est pas entéro-soluble.
Lundberg Per Johan
Sjoblom Brita
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
New formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New formulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1860189